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ABSTRACT 
Mustard (Brassica juncea) leaves are commonly consumed in different Asian and African countries. Cancer is a 
major burden of disease worldwide, and the colorectal and lung cancers are the leading cause of morbidity and 
mortality among cancers. In the current study, we aimed to investigate the effects of ethanol extract of mustard 
leaf (MLE) on the growth, angiogenic, and metastatic potentials of HCT116 colorectal carcinoma and H1299 
non-small cell lung carcinoma cells in vitro. Treatment of HCT116 and H1299 cells with MLE inhibited cell 
growth in a dose-dependent manner (in the range of 175-700 µg/ml, by 39-86 %) and anchorage-independent 
colonization (at 700 µg/ml, by 56-86 %). Induction of apoptosis by MLE was evidenced by heterogeneous and 
condensed nucleus morphology, increased 4′,6-diamidino-2-phenylindole dihydrochloride staining intensity, and 
elevated sub-G1 cell population. In both HCT116 and H1299 cells, treatment with MLE markedly suppressed 
the secretion of key pro-angiogenic factors, such as vascular endothelial cell growth factor (by >92 %) and basic 
fibroblast growth factor (by 73-94 %). MLE was also effective in inhibiting critical events during metastasis, 
such as invasion (by 18-33 % in HCT116 and H1299), migration (45-82 % in H1299), and adhesion (by 17-45 % 
in HCT116 and H1299). These results indicate that MLE possesses in vitro anti-cancer activities against colon 
and lung cancers. It needs to be verified whether similar effects are reproduced in vivo.  
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INTRODUCTION 
Cancer is a major burden of disease 
worldwide, and the colorectal and lung can-
cers are the leading cause of morbidity and 
mortality among cancers (Jemal et al., 2009). 
Carcinogenesis is recognized as a multistep 
process where normal cells evolve progres-
sively to a tumorigenic and ultimately ma-
lignant state by sustaining unrestricted 
growth, resisting apoptosis, inducing angio-
genesis, and activating metastasis (Hanahan 
and Weinberg, 2011). Unrestricted growth is 
arguably the most fundamental trait of neo-
plastic cells, which is partially acquired by 
resisting a programmed cell death, called 
apoptosis (Hanahan and Weinberg, 2011). 
Angiogenesis is a process where new blood 
vessels are formed from existing ones within 
primary tumor and plays a key role in ex-
panding the neoplastic cell growth by sup-
plying oxygen and nutrients and in mediating 
metastatic spread of neoplastic cells (Hana-
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han and Weinberg, 2011; Folkman, 2002). 
Metastasis is a complex phenomenon where 
neoplastic cells grown in a primary tumor 
invade surrounding tissues, penetrate blood 
vessels, exit vessels at distant sites, and form 
secondary tumors (Hanahan and Weinberg, 
2011; Kumar and Weaver, 2009). Diet is re-
garded as an important modifying factor in 
the etiology of cancers (McCullough and 
Giovannucci, 2004). Identification of effec-
tive and safe dietary compounds targeting 
distinct properties of cancer cells acquired 
during the multistep carcinogenesis would 
have significant implication in cancer pre-
vention and treatment. 
Mustard (Brassica juncea) leaves, one of 
the cruciferous vegetables, are consumed in 
different Asian and African countries (Tiku 
et al., 2008; Lee et al., 2010; Yokozawa et 
al., 2003; Grubben and Denton, 2004). High 
intake of cruciferous vegetables has been in-
versely associated with the risk of several 
cancers, most consistently colon and lung 
cancers (Higdon et al., 2007). Mustard leaf 
extract (MLE) has been reported to possess 
different biological activities, including anti-
oxidant (Kim et al., 2003; Yokozawa et al., 
2002b, 2003; Tiku et al., 2008), anti-
inflammatory (Kim et al., 2005), renal is-
chemia-protective (Yokozawa et al., 2002a), 
and anti-depressant activities (Thakur et al., 
2014). Cytotoxic effects of MLE have also 
been reported in different cancer cells, in-
cluding colon, lung, gastric, and breast can-
cer cells (Kim et al., 2007). However, anti-
cancer effects of MLE other than the cyto-
toxicity have not been reported.  
The objective of the current study was to 
systematically evaluate the effects of MLE 
on the growth, anchorage-independent colo-
ny formation, apoptosis, pro-angiogenic fac-
tor secretion, invasion, migration, and adhe-
sion of human colon and lung cancer cells in 
vitro. 
 
MATERIALS AND METHODS 
Preparation of mustard leaf extract 
Green mustard leaves (purchased from a 
local market) were washed, freeze-dried 
(PH1316, IshinBioBase, Yangju, Korea), and 
extracted with 70 % ethanol at room temper-
ature for 4 h. After centrifugation at 3,000g 
for 3 min, the supernatant was dried using a 
speed vacuum (NB-503CIR, N-bioteck, 
Bucheon, Korea) to remove the ethanol. The 
resultant extract was weighed (34.7  0.5 % 
of extraction yield calculated by the mass of 
extract/the mass of dried leaves) and kept at -
70 °C for further analysis.  
 
Cell culture and general scheme of  
treatment 
HCT116 human colorectal carcinoma 
cells and H1299 human non-small cell lung 
carcinoma cells (Korean Cell Line Bank, 
Seoul, Korea) were grown in Macoy’s 5A 
(for HCT116) and RPMI (for H1299) medi-
um (Gibco Co., Rockville, MD, USA) con-
taining 10 % fetal bovine serum (FBS; 
Thermo Scientific, Logan, UT, US) and 1 % 
penicillin/streptomycin (Welgene Inc., Dae-
gu, Korea) at 37 °C in a humidified 5 % 
CO2. The dried extracts were reconstituted in 
dimethyl sulfoxide (DMSO) not exceeding 
the final DMSO concentration of 0.2 % 
(v/v). The effects of MLE on pro-angiogenic 
factor secretion, invasion, migration, and ad-
hesion were studied at a maximum of 24 h 
time point when HCT116 and H1299 cell vi-
ability was not significantly affected by 
MLE at the concentration range used (175-
700 µg/ml). 
 
Cell viability assay 
To determine the effect of MLE on an-
chorage-dependent cell growth, the 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazoli-
um bromide (MTT) assay was performed as 
previously described (Ju et al., 2012). Brief-
ly, HCT116 and H1299 cells were plated in 
96-well plates (5 × 103 cells/well) and al-
lowed to attach for 24 h. The culture media 
were replaced with fresh serum free media 
containing different concentrations of MLE 
(0, 175, 350, and 700 µg/ml). Cells were 
then incubated with a respective concentra-
tion of MLE for 72 and 96 h. The media was 
removed, and 0.5 mg/mL of MTT-containing 
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fresh media was added in each well. After 
4 h incubation at 37 °C, the water insoluble 
formazan product was produced by metabol-
ically active cells and dissolved with the ad-
dition of DMSO. Viable cells were quanti-
fied spectrophotometically using a plate 
reader (Bio-Rad Laboratories, Hercules, CA, 
US) at the wavelength of 540 nm.  
 
Soft agar colony formation assay 
To determine the effect of MLE on an-
chorage-independent cell growth, a soft agar 
assay was performed as previously described 
(Irons et al., 2010; Kwak and Ju, 2015). 
Briefly, culture media containing 0.6 % agar 
(DC Chemical Co., Seoul, Korea) was pre-
solidified as a base layer in 6-cm culture 
dishes. HCT116 (6 × 104 cells/well) and 
H1299 (8 × 103 cells/well) cells were then 
suspended in culture media containing 0.3 % 
agar and layered onto the base layer. Serum 
complete media containing MLE at the con-
centration of 700 µg/ml was applied on top 
of the 0.3 % agar layer, and then cells were 
cultured for 21 days. Colonies were stained 
using 0.05 % crystal violet in 20 % methanol 
for 1 h, and the images of 4 random fields 
per well were captured (iSolution Lite soft-
ware, IMT i-solution, Burnarby, Canada). 
The number and size (in the largest diameter) 
of colonies were quantified using phase con-
trast time-lapse microscopy (X100; Primo 
Vert, Carl Zeiss, Oberkochen, Germany).  
 
Staining of cell nucleus  
To determine the effect of MLE on apop-
tosis, 4′,6-diamidino-2-phenylindole dihy-
drochloride (DAPI) staining assay was per-
formed as described previously (Toton et al., 
2013). Briefly, HCT116 and H1299 cells on 
8-well chamber slide (7 × 103 cells/well) 
were incubated with serum free media con-
taining different concentrations of MLE (0, 
175 and 700 µg/ml) for 24 h. Apoptotic cells 
were visualized by staining the double-
stranded DNA of cells with impaired mem-
branes using a fluorescent dye, DAPI (Sig-
ma-Aldrich). Then, cells were washed with 
PBS, fixed with 4 % formaldehyde (Sigma-
Aldrich) for 15 min at room temperature, and 
incubated with DAPI. Cells with degraded or 
condensed nuclei (Fesik, 2005; Florent et al., 
1999) were observed under confocal laser 
scanning microscopy (X200; MRC-1024, 
Bio-Rad Laboratories), and the staining in-
tensity of DAPI was quantified using Image-
J software (NIH, Bethesda, MD, USA).   
 
Cell cycle analysis 
To determine the effect of MLE on cell 
cycle, starved HCT116 and H1299 cells (3 × 
105 cells/well) were cultured in serum com-
plete media containing 0 or 700 µg/ml of 
MLE for 72 h (HCT116) or 48 h (H1299). 
Cells were then harvested by trypsinization, 
fixed in 70 % ethanol overnight at -20 °C, 
incubated with Ribonuclease A (1 µg/ml; 
Sigma-Aldrich) and propidium iodine 
(50 µg/ml; Sigma-Aldrich) for 20 min in the 
dark at room temperature. Cell population at 
Sub-G1, G1/G0, S, and G2/M phases were 
identified according to the DNA content us-
ing a flow cytometer (FACS Calibur-S Sys-
tem, BD Biosciences, Heidelberg, Germany) 
and Cell Quest Pro software (BD Bioscienc-
es). 
 
Enzyme linked immunosorbent assay for 
measurement of pro-angiogenic factor  
levels 
To determine the effect of MLE on the 
secretion of key pro-angiogenic factors, such 
as vascular endothelial cell growth factor 
(VEGF) and basic fibroblast growth factor 
(bFGF) (Folkman, 2002), enzyme linked 
immunosorbent assay (ELISA) was per-
formed. Briefly, HCT116 and H1299 cells 
were plated in 24-well plates (5 × 104 
cells/well) and incubated with serum free 
media containing different concentrations of 
MLE (0-700 µg/ml) for 24 h. The media was 
then collected and centrifuged at 3,000g for 
1 min. Levels of VEGF and bFGF were 
measured using ELISA kits (Koma Biotech 
Inc., Seoul, Korea) according to the manu-
facturer’s instruction.  
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Transwell invasion assay 
To determine the effect of MLE on cell 
invasion, a transwell assay was performed, 
as previously described (Ju et al., 2012). 
Briefly, transwell chambers (8 µm pore size; 
Corning Inc.) were coated with matrigel 
(1 mg/ml, Sigma-Aldrich) for 2 h at 37 °C. 
HCT116 and H1299 cells (1 × 106 cells/well) 
were loaded in the matrigel-coated inner 
chambers containing serum free media with 
MLE (0-700 µg/ml). Cells were then allowed 
to invade through the matrigel layer toward 
the outer chamber containing serum com-
plete media. At 24 h after the treatment, the 
cells still present on the upper surface of the 
inner chamber were removed using cotton 
swabs. Then, the cells penetrated to the low-
er surface of inner chamber and are further 
present in the outer chamber were stained 
with 0.2 % crystal violet in 20 % methanol 
for 1 h. After washing the stained cells with 
PBS, the dye was released from the cells by 
the addition of 1 % sodium dodecyl sulfate 
(SDS; Sigma-Aldrich). Invaded cells were 
quantified spectrophotometically using a 
plate reader (Bio-Rad Laboratories) at the 
wavelength of 540 nm.  
 
Wound healing cell migration assay 
To determine the effect of MLE on cell 
migration, a wound healing assay was per-
formed as described previously (Kwak and 
Ju, 2015). Briefly, HCT116 and H1299 cells 
on 6-well plates (5 × 103 cells/well) were 
scratched using a yellow pipette tip in order 
to introduce a wound. Detached floating 
cells were removed by washing with PBS. 
The attached cells were then maintained with 
serum free media containing different con-
centrations of MLE (0-700 µg/ml) and per-
mitted to migrate for 24 h. The images of 
wound were captured by iSolution Lite soft-
ware (IMT i-solution, Burnarby, Canada), 
and the wound closure for 24 h was estimat-
ed using Image-J software (NIH).  
 
Cell adhesion assay 
To determine the effect of MLE on cell 
adhesion, an assay using fibronectin-coated 
plate was performed as previously described 
(Matsuura et al., 2006; Kwak and Ju, 2015). 
Briefly, 1 μg/ml fibronectin (Sigma-Aldrich) 
and 0.5 % bovine serum albumin (Sigma-
Aldrich) were sequentially added in 96-well 
plates with 2 h interval at 37°C. HCT116 and 
H1299 cells were mixed with serum com-
plete media containing MLE (0-700 µg/ml) 
and seeded in the fibronectin-coated 96-well 
plates (1 × 103 cells/well). After 2 h, unat-
tached cells were washed out with PBS. At-
tached cells were incubated with 0.2 % crys-
tal violet (in 20 % methanol) for 10 min at 
room temperature. After dissolving the 
stained cells by 1 % SDS (Sigma-Aldrich), 
adherent cells were quantified spectropho-
tometically using a plate reader (Bio-Rad 
Laboratories) at the wavelength of 540 nm.  
 
Statistical analyses 
Data were present as mean ± SEM of at 
least three determinations. Two groups were 
compared by Student’s t-test, and multiple 
groups were compared by one-way ANOVA 
followed by Duncan test. The relationship 
between a dose and response was assessed 
by regression analysis. Significance was 
achieved at p values less than 0.05. 
 
RESULTS 
MLE inhibited anchorage-dependent and  
-independent growth in human colon and 
lung cancer cells  
Cancer cells have an ability to grow an-
chorage-dependently and -independently 
(Hanahan and Weinberg, 2011). We evaluat-
ed the inhibitory effect of MLE against the 
anchorage-dependent and -independent 
growth by a typical MTT and soft agar colo-
ny formation assay, respectively. In HCT116 
human colon cancer cells, the treatment with 
MLE at the concentration of 175, 350, and 
700 µg/ml for 72 h and 96 h significantly in-
hibited the anchorage-dependent growth by 
39-86 %, showing estimated IC50 values of 
253 µg/ml at the 72 h time point and 
153 µg/ml at the 96 h time point (Figure 1). 
MLE was also effective in inhibiting the 
growth of H1299 human lung cancer cells; 
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the treatment with MLE at the concentration 
of 175, 350, and 700 µg/ml for 72 h and 96 h 
inhibited the growth by 56-72 % (IC50 value, 
~130 µg/ml) (Figure 1). In the following re-
gression analysis, a significant dose-response 
relationship was detected in both HCT116 
and H1299 cells (R2>0.85, p<0.001). 
At being cultured for 21 days, both 
HCT116 and H1299 cells formed a substan-
tial number of colonies in soft agar (Figure 
2), indicating their property of anchorage-
independent growth (Ballet et al., 1981). The 
treatment with MLE at the concentration of 
700 µg/ml significantly reduced the number 
of colonies by 56 % in HCT116 cells and by 
86 % in H1299 cells (Figure 2). In H1299 
cells producing much bigger size of colonies 
than HCT116 cells (Kwak and Ju, 2015), the 
treatment with MLE at the concentration of 
700 µg/ml also reduced the size of colonies 
significantly (by 25 %; Figure 2B).  
 
 
Figure 1: Effect of MLE on the anchorage-dependent growth of HCT116 human colon cancer cells 
and H1299 human lung cancer cells. HCT116 (A) and H1299 (B) cells were incubated with different 
concentrations of MLE (0-700 µg/ml) for 72 h and 96 h. Viable cells were determined by the MTT as-
say as described in Materials and Methods. Statistically significant differences among groups were in-
dicated with different letters (a-d, p<0.05 by Duncan test). 
 
 
 
Figure 2: Effect of MLE on the anchorage-independent colony formation of HCT116 human colon 
cancer cells and H1299 human lung cancer cells. HCT116 (A) and H1299 (B) cells on soft agar were 
incubated with different concentrations of MLE (0 or 700 µg/ml) for 21 days. The number (in HCT116 
and H1299 cells) and size (in H1299 cells) of colonies stained with crystal violet were determined un-
der phase contrast time-lapse microscopy (X100), and representative colonies were present. Statisti-
cally significant differences between untreated control and MLE-treated cells were indicated with as-
terisks (*p<0.05, ***p<0.001, by two-tailed student t-test).  
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MLE induced apoptosis in human colon 
and lung cancer cells 
Loss of apoptotic function is a critical 
feature of cancer cells and leads to malignant 
cell growth (Fesik, 2005). We next investi-
gated the apoptosis-inducing activities of 
MLE by visualizing cell nuclei using a 
DNA-staining dye, DAPI. The control 
HCT116 (data not shown) and H1299 cells 
(Figure 3A) presented a typical morphology 
of healthy cancer cells with homogeneous 
and symmetric shape of nuclei. The cells 
treated with MLE at 175 and 700 µg/ml, 
however, displayed morphological character-
istics of apoptotic cells with heterogeneous 
and condensed nuclear chromatin (Figure 
3A) (Fesik, 2005; Florent et al., 1999). 
Apoptotic cells are known to show increased 
DAPI staining intensity due to their in-
creased membrane permeability (Hotz et al., 
1994). The nucleus of control HCT116 and 
H1299 cells were stained with DAPI very 
weekly, as expected. On the other hand, the 
nucleus of cells treated with MLE at the con-
centrations of 175 and 700 µg/ml showed in-
creased DAPI staining intensity in both 
HCT116 (to 127-160 % of the control; 
p<0.05; Figure 3A) and H1299 cells (to 157-
161 % of the control; p<0.05; Figure 3A), 
indicating the induction of apoptosis by 
MLE. Cell cycle analyses also revealed the 
apoptosis-inducing activity of MLE; MLE 
(at 700 µg/ml) increased the number of cells 
in the sub-G1 phase (to ~1.5-fold of control 
HCT116 and H1299 cells, Figure 3B). Cell 
populations at other phases were not signifi-
cantly changed by the treatment with MLE 
(data are not shown). 
 
 
Figure 3: Effect of MLE on apoptosis in HCT116 human colon cancer cells and H1299 human lung 
cancer cells. DAPI staining intensity (A) of HCT116 and H1299 cells incubated with 0, 175, and 700 
µg/ml of MLE for 48 h was estimated, and representative nuclear morphology of H1299 cells was 
shown on the right panel. Statistically significant differences among groups were indicated with differ-
ent letters (a-c, p<0.05 by Duncan test). Cell cycle distribution (B) of HCT116 and H1299 cells treated 
with 0 or 700 µg/ml concentration of MLE was analyzed, and the cell population ( %) at sub-G1 (M4) 
phase was shown. Statistically significant differences between untreated control and MLE-treated cells 
were indicated with asterisks (*p<0.05 by two-tailed student t-test). 
EXCLI Journal 2016;15:699-710 – ISSN 1611-2156 
Received: August 17, 2016, accepted: October 29, 2016, published: November 15, 2016 
 
 
705 
MLE decreased the secretion of  
pro-angiogenic factors in human colon  
and lung cancer cells  
Angiogenesis is triggered by the local 
production of key pro-angiogenic factors 
from tumor cells, including VEGF and bFGF 
(Hanahan and Weinberg, 2011). We investi-
gated the effects of MLE on VEGF and 
bFGF secretion of HCT116 and H1299 cells 
by ELISA. Both control HCT116 and H1299 
cells secreted appreciable levels of VEGF 
(~40 pg/ml in HCT116 and ~80 pg/ml in 
H1299) and bFGF (~54 pg/ml in HCT116 
and ~67 pg/ml in H1299). Treatment of 
HCT116 and H1299 cells with MLE at the 
concentrations of 175, 350, and 700 µg/ml 
virtually nullified the VEGF secretion (by 
>92 %, Figure 4) and markedly suppressed 
the bFGF secretion (by 73-94 %, Figure 4).  
 
MLE inhibited invasion in human colon 
and lung cancer cells 
Invasion of cells grown in the primary 
tumor into surrounding stroma is the first 
step of cancer metastasis (Hanahan and 
Weinberg, 2011). We studied the effects of 
MLE on the invasion of human cancer cells 
by a transwell assay. Both control HCT116 
and H1299 cells displayed invasive proper-
ties, as previously reported (Qian et al., 
2013; Liao et al., 2015). Treatment with 
MLE at 175, 350, and 700 µg/ml concentra-
tions suppressed the invasion of HCT116 
cells by 18-33 % and H1299 cells by 25-
28 % (Figure 5). 
Figure 4: Effect of PLE on pro-angiogenic factor secretion of HCT116 human colon cancer cells and 
H1299 human lung cancer cells. HCT116 (A) and H1299 (B) cells were incubated with different con-
centrations of MLE (0-700 µg/ml) for 24 h. The culture media was then collected, and levels of VEGF 
and bFGF were determined by ELISA. Statistically significant differences among groups were indicat-
ed with different letters (a-c, p<0.05 by Duncan test).  
 
 
Figure 5: Effect of MLE on inva-
sion in HCT116 human colon 
cancer cells and H1299 human 
lung cancer cells. HCT116 (A) 
and H1299 (B) cells were loaded 
in the matrigel-coated inner 
chambers containing serum free 
media with different concentra-
tions of MLE (0-700 µg/ml) and 
then allowed to invade through 
the matrigel layer toward the out-
er chamber containing serum 
complete media. After 24 h, cells 
present in the lower surface of inner chamber and the outer chamber were stained with 0.2 % crystal 
violet. After dissolving the dye with 1 % SDS, invaded cells were quantified by reading the absorbance 
at 540 nm using using a plate reader. Statistically significant differences among groups were indicated 
with different letters (a-d, p<0.05 by Duncan test). 
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MLE inhibited migration in human colon 
and lung cancer cells 
Migration of cancer cells is prominent 
event in metastatic cascade (Hanahan and 
Weinberg, 2011). We evaluated the effects 
of MLE on the migration of human cancer 
cells by a wound healing assay. Both control 
HCT116 and H1299 cells displayed migra-
tive properties, as observed previously 
(Kwak and Ju, 2015). The treatment of 
H1299 cells with MLE at the concentrations 
of 175, 350, and 700 µg/ml significantly re-
duced the wound closure by 45-82 % (Figure 
6) in a dose-dependent manner (R2>0.8, 
p<0.001 by regression analysis). In HCT116 
cells migrating slowly compared to H1299 
cells (Kwak and Ju, 2015), the treatment 
with MLE only resulted in a trend of reduc-
ing the wound closure (at ≥350 µg/ml), but 
the changes were not statistically significant 
(Figure 6). 
 
MLE inhibited adhesion in human colon 
and lung cancer cells  
Cell adhesion to extracellular matrix is a 
critical step during metastasis (Hanahan and 
Weinberg, 2011). We determined the effect 
of MLE on the adhesion of human cancer 
cells to fibronectin, a key adhesive glycopro-
tein of extracellular matrix (Ruoslahti, 
1984). The treatment with MLE at 175, 350, 
and 700 µg/ml concentrations inhibited the 
adhesion by 20-39 % (p<0.05, Figure 7). In 
H1299 cells, MLE at 350 and 700 µg/ml 
concentrations was effective in inhibiting the 
adhesion (by 17-45 %, p<0.05). 
 
 
Figure 6: Effect of MLE on migration in HCT116 human colon cancer cells and H1299 human lung 
cancer cells. HCT116 (A) and H1299 (B) cells were incubated with different concentrations of MLE (0 
or 700 µg/ml) for 24 h. The closure of wound for 24 h was estimated, and representative image of 
wound of H1299 cells (at 0 h and 24 h time points) were shown. Statistically significant differences 
among groups were indicated with different letters (a-c, p<0.05 by Duncan test).  
 
 
 
Figure 7: Effect of MLE on ad-
hesion in HCT116 human colon 
cancer cells and H1299 human 
lung cancer cells. HCT116 (A) 
and H1299 (B) cells suspended 
in serum complete media con-
taining different concentrations 
of MLE (0-700 µg/ml) were add-
ed into plate coated with fibron-
ectin. After 2 h, attached cells on 
the bottom of plate were quanti-
fied. Statistically significant dif-
ferences among groups were 
indicated with different letters (a-
c, p<0.05 by Duncan test).  
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DISCUSSION 
Cancer arises from normal cells as a con-
sequence of multistep carcinogenesis (Hana-
han and Weinberg, 2011). Critical properties 
that cells attain sequentially to become tu-
morigenic and ultimately malignant during 
the multistep carcinogenesis include sustain-
ing unrestricted growth, resisting apoptosis, 
inducing angiogenesis, and activating metas-
tasis (Hanahan and Weinberg, 2011). In the 
present study, we aimed to investigate in-
hibitory activities of MLE against such criti-
cal properties using highly proliferative, an-
giogenic, and metastatic human cancer cells 
lines, HCT116 (colon cancer cells) and 
H1299 (lung cancer cells) (Li et al., 2013; 
Tang et al., 2012; Xia et al., 2016; Kim et al., 
2014). 
Uncontrolled growth and inactivated 
apoptosis are key features of cancer cells 
(Hanahan and Weinberg, 2011). The inhibi-
tion of growth and restoration of apoptosis in 
cancer cells are, therefore, regarded as an ef-
fective strategy for cancer prevention and 
treatment (Fesik, 2005; Hanahan and 
Weinberg, 2011). The results of our study 
indicated that MLE exhibited strong growth-
inhibitory (Figures 1&2) and apoptotic-
inducing activities (Figure 3) in both 
HCT116 and H1299 cells. Since the loss of 
apoptotic function contributes to the uncon-
trolled growth of cancers (Hanahan and 
Weinberg, 2011), our findings suggest that 
the growth-inhibitory activities of MLE may 
be acquired at least partially by its apoptosis-
inducing activity. The anchorage-independ-
ent growth in vitro is known to be well cor-
related with tumorigenecity in vivo (Ballet et 
al., 1981). Our findings on the inhibition of 
anchorage-independent growth of HCT116 
and H1299 cells by MLE (Figure 2) suggest 
inhibitory activities of MLE against tumor-
igenic potentials of colon and lung cancer 
cells (Fesik, 2005). Although cytotoxic ef-
fects of MLE have been reported previously 
in colon, lung, gastric, and breast cancer 
cells (Kim et al., 2007), this is the first re-
port, to the best of our knowledge, on the in-
hibitory activity against anchorage-inde-
pendent growth-inhibitory and apoptosis-
inducing activities of MLE in human cancer 
cells.  
Angiogenesis is a process of forming 
new blood vessels by endothelial cells from 
existing micro vessels (Hanahan and 
Weinberg, 2011). Since the new blood 
grown into the primary tumor provide the 
necessary oxygen, nutrients, and growth fac-
tors for tumor progression, angiogenesis is 
regarded as an important target in cancer 
prevention and treatment (Granci et al., 
2010). Angiogenesis is triggered by the en-
dogenous production of specific pro-
angiogenic factors secreted from tumor cells 
(Folkman, 2002). VEGF and bFGF are re-
garded as most potent mediators of angio-
genesis (Folkman, 2002; Gupta and Qin, 
2003), and VEGF appears to play a dormant 
role in different cancers, including cancers of 
colon and lung (Frandsen et al., 2016). Our 
results indicate that MLE suppressed VEGF 
and bFGF secretion of HCT116 and H1299 
cells (Figure 4). Particularly, the secretion of 
VEGF was almost nullified by the treatment 
with MLE (Figure 4). These results suggest 
inhibitory activities of MLE against angio-
genic potentials of colon and lung cancer 
cells. Since VEGF and bFGF produced by 
primary tumor cells also contribute to pro-
moting cell proliferation in an autocrine 
manner (Cao et al., 2012; Berger et al., 
1999), the inhibition of pro-angiogenic factor 
secretion by MLE (Figure 4) may partially 
explain the growth-inhibitory activities of 
MLE (Figure 1). 
Metastasis is a major cause of cancer-
related death (Hanahan and Weinberg, 
2011), and therefore, extensive research has 
been conducted in order to identify effective 
anti-metastatic agents (Shu et al., 2010). In-
vasion, migration, and adhesion to extracel-
lular matrix are key events that neoplastic 
cells must undergo during metastatic cascade 
(Hanahan and Weinberg, 2011). Our results 
indicate that MLE inhibited the invasion and 
adhesion in both HCT116 and H1299 cells 
as well as the migration in H1299 cells (Fig-
ures 5-7). To the best of our knowledge, this 
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is the first study reporting such inhibitory ac-
tivities of MLE as well as the inhibition of 
pro-angiogenic factor secretion (Figure 4) in 
human cancer cells. Such inhibitory activi-
ties of MLE was observed at the time points 
when cell viability was not affected (2-24 h) 
and, therefore, may not be due to the cyto-
toxicity of MLE. 
The ethanol extract of mustard leaves 
used in the present study is a complex mix-
ture containing different bioactive phyto-
chemicals. The anticancer effects of crucif-
erous vegetables have been ascribed to glu-
cosinolates and their hydrolysis products, in-
cluding indoles and isothiocyanates (Higdon 
et al., 2007). It needs to be further identified 
which constituent(s) is (are) most responsi-
ble for the inhibitory activities of MLE 
found in the present study.  
In summary, treatment with MLE dose-
dependently inhibited the growth in HCT116 
human colon cancer cells and H1299 human 
lung cancer cells, and this was accompanied 
by the induction of apoptosis. MLE was also 
effective in suppressing the anchorage-
independent colony formation, pro-
angiogenic factor secretion, invasion, and 
adhesion in HCT116 and H1299 cells as well 
as the migration in H1299 cells. Our results 
indicate that MLE possesses anti-cancer ac-
tivities against colon and lung cancers in 
vitro. It still needs to be determined whether 
or not similar effects were reproduced in rel-
evant animal models and finally humans. 
More studies are needed to demonstrate un-
derlying cellular and molecular mechanisms 
of the inhibitory activities observed in the 
present study, which will help to better de-
fine the preventive and therapeutic potentials 
of MLE against human colon and lung can-
cers.  
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